Business Details
Specialty Pharmaceutical Solutions for Unmet Medical Needs
Cipher Pharmaceuticals is a specialty pharmaceutical company dedicated to addressing unmet medical needs through innovative product development and strategic partnerships. Our focus spans dermatology, hospital acute care, and specialty medicine, with a robust portfolio of commercial and late-stage products. We manage the entire lifecycle of our products, from clinical development and regulatory approval to marketing across Canada, the U.S., and South America. Our lean corporate structure and operational partnerships enable efficient execution and flexibility in a dynamic industry. With two product candidates currently in Phase III studies, we remain committed to advancing therapies that improve patient outcomes.Our business development strategy prioritizes mergers and acquisitions that align with our existing product offerings and market expertise. Through global partnerships, we generate royalty revenue while expanding our dermatology pipeline. Our team of professionals brings deep industry experience to every stage of drug development and commercialization. We prioritize collaboration with healthcare professionals to ensure our products meet clinical needs effectively. Our mission is to deliver value through innovation, rigorous scientific research, and patient-centric solutions that enrich medical practices and enhance healthcare delivery.
Services
Dermatology Products
Hospital Acute Care
Out-Licensed Products
Specialty Medicine
Pipeline Development
Highlights and features
- We offer a robust portfolio of commercial and late-stage pharmaceutical products.
- Our team manages clinical development and regulatory approval processes globally.
- We operate in North America and South America with strategic partnerships.
- Our pipeline includes two product candidates in Phase III studies.
- We focus on unmet medical needs through innovative therapeutic solutions.
Services
Dermatology Products
We develop and acquire dermatology products addressing conditions like actinic keratosis, severe acne, and unwanted facial hair. Our solutions offer efficacy, flexibility, and convenience for healthcare professionals and patients. Products include Actikerall, Epuris, and Vaniqa, with clinical focus on improving patient outcomes.
Hospital Acute Care
Our hospital acute care products target urgent medical needs, including anticoagulants and antiarrhythmics. Aggrastat and Brinavess support treatment of acute coronary syndrome and atrial fibrillation. These therapies are designed for rapid clinical response in critical care settings.
Out-Licensed Products
Through global partnerships, we license products like Absorica and ConZip, generating royalty revenue. These collaborations expand our portfolio while supporting pipeline development. Our licensed brands address dermatological and chronic pain management needs.
Specialty Medicine
We provide specialty medicines for niche therapeutic areas, including lipid-lowering agents and antiparasitics. Products like Lipofen and Natroba address specific patient populations, combining clinical innovation with targeted treatment approaches.
Pipeline Development
Our pipeline includes two candidates in Phase III studies, focusing on unmet medical needs. We prioritize clinical development and regulatory approval for innovative therapies. This pipeline drives long-term growth and expands our therapeutic offerings.
Questions
What therapeutic areas does Cipher Pharmaceuticals focus on?
We focus on dermatology, hospital acute care, and specialty medicine, addressing unmet medical needs through innovative product development.
Where are Cipher's products available?
Our products are marketed in Canada, the United States, and South America through direct and partnership channels.
How does Cipher develop its product pipeline?
We acquire, license, and develop products, managing clinical trials and regulatory approvals to advance therapies through Phase III studies.
How can healthcare professionals access product information?
Product monographs and prescribing information are available for download on our website for all commercial products.
